Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Tiara, Hassan"'
Autor:
Weang-Kee Ho, Nur Tiara Hassan, Sook-Yee Yoon, Xin Yang, Joanna M.C. Lim, Nur Diana Binte Ishak, Peh Joo Ho, Eldarina A. Wijaya, Patsy Pei-Sze Ng, Craig Luccarini, Jamie Allen, Mei-Chee Tai, Jianbang Chiang, Zewen Zhang, Mee-Hoong See, Meow-Keong Thong, Yin-Ling Woo, Alison M. Dunning, Mikael Hartman, Cheng-Har Yip, Nur Aishah Mohd Taib, Douglas F. Easton, Jingmei Li, Joanne Ngeow, Antonis C. Antoniou, Soo-Hwang Teo
Publikováno v:
The Lancet Regional Health. Western Pacific, Vol 44, Iss , Pp 101017- (2024)
Summary: Background: Clinical management of Asian BRCA1 and BRCA2 pathogenic variants (PV) carriers remains challenging due to imprecise age-specific breast (BC) and ovarian cancer (OC) risks estimates. We aimed to refine these estimates using six mu
Externí odkaz:
https://doaj.org/article/98fce87ebcdf49c88046d79e3ec0f863
Autor:
Peh Joo Ho, Weang Kee Ho, Alexis J. Khng, Yen Shing Yeoh, Benita Kiat-Tee Tan, Ern Yu Tan, Geok Hoon Lim, Su-Ming Tan, Veronique Kiak Mien Tan, Cheng-Har Yip, Nur-Aishah Mohd-Taib, Fuh Yong Wong, Elaine Hsuen Lim, Joanne Ngeow, Wen Yee Chay, Lester Chee Hao Leong, Wei Sean Yong, Chin Mui Seah, Siau Wei Tang, Celene Wei Qi Ng, Zhiyan Yan, Jung Ah Lee, Kartini Rahmat, Tania Islam, Tiara Hassan, Mei-Chee Tai, Chiea Chuen Khor, Jian-Min Yuan, Woon-Puay Koh, Xueling Sim, Alison M. Dunning, Manjeet K. Bolla, Antonis C. Antoniou, Soo-Hwang Teo, Jingmei Li, Mikael Hartman
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-11 (2022)
Abstract Background Family history, and genetic and non-genetic risk factors can stratify women according to their individual risk of developing breast cancer. The extent of overlap between these risk predictors is not clear. Methods In this case-onl
Externí odkaz:
https://doaj.org/article/a1cd5204e97c4a85a285a67209cba529
Autor:
Heamanthaa Padmanabhan, Nur Tiara Hassan, Siu-Wan Wong, Yong-Quan Lee, Joanna Lim, Siti Norhidayu Hasan, Cheng-Har Yip, Soo-Hwang Teo, Meow-Keong Thong, Nur Aishah Mohd Taib, Sook-Yee Yoon
Publikováno v:
PLoS ONE, Vol 17, Iss 2 (2022)
There is an increasing number of cancer patients undertaking treatment-focused genetic testing despite not having a strong family history or high a priori risk of being carriers because of the decreasing cost of genetic testing and development of new
Externí odkaz:
https://doaj.org/article/d8962a9a727549f79753e8b8e971eb57
Autor:
Heamanthaa Padmanabhan, Shivaani Mariapun, Sheau‐Yee Lee, Nur Tiara Hassan, Daphne Shin‐Chi Lee, Bettina Meiser, Siu‐Wan Wong, Yong‐Quan Lee, Cheng‐Har Yip, Soo‐Hwang Teo, Meow‐Keong Thong, Nur Aishah Mohd Taib, Sook‐Yee Yoon
Publikováno v:
Journal of Genetic Counseling. 32:43-56
Cascade testing for families with BRCA pathogenic variants is important to identify relatives who are carriers. These relatives can benefit from appropriate risk management and preventative strategies arising from an inherited increased risk of breas
Predicting the Likelihood of Carrying a BRCA1 or BRCA2 Mutation in Asian Patients With Breast Cancer
Autor:
Boon Hong Ang, Weang Kee Ho, Eldarina Wijaya, Pui Yoke Kwan, Pei Sze Ng, Sook Yee Yoon, Siti Norhidayu Hasan, Joanna M.C. Lim, Tiara Hassan, Mei-Chee Tai, Jamie Allen, Andrew Lee, Nur Aishah Mohd Taib, Cheng Har Yip, Mikael Hartman, Swee Ho Lim, Ern Yu Tan, Benita K.T. Tan, Su-Ming Tan, Veronique K.M. Tan, Peh Joo Ho, Alexis J. Khng, Alison M. Dunning, Jingmei Li, Douglas F. Easton, Antonis C. Antoniou, Soo Hwang Teo
Publikováno v:
Journal of Clinical Oncology. 40:1542-1551
PURPOSE With the development of poly (ADP-ribose) polymerase inhibitors for treatment of patients with cancer with an altered BRCA1 or BRCA2 gene, there is an urgent need to ensure that there are appropriate strategies for identifying mutation carrie
Autor:
Yong‐Quan Lee, Sook‐Yee Yoon, Tiara Hassan, Heamanthaa Padmanabhan, Cheng‐Har Yip, Wee‐Teik Keng, Meow‐Keong Thong, Muhammad Azrif Ahmad Annuar, Nur Aishah Mohd Taib, Soo‐Hwang Teo
Publikováno v:
Journal of Genetic Counseling. 31:1080-1089
With the advent of poly-ADP-ribose polymerase inhibitor (PARPi) therapies, the focus of genetic testing for breast, ovarian, and other cancers has shifted from risk management to treatment decision-making in high-resource settings. Due to the shortag
Autor:
Weang-Kee Ho, Mei-Chee Tai, Joe Dennis, Xiang Shu, Jingmei Li, Peh Joo Ho, Iona Y. Millwood, Kuang Lin, Yon-Ho Jee, Su-Hyun Lee, Nasim Mavaddat, Manjeet K. Bolla, Qin Wang, Kyriaki Michailidou, Jirong Long, Eldarina Azfar Wijaya, Tiara Hassan, Kartini Rahmat, Veronique Kiak Mien Tan, Benita Kiat Tee Tan, Su Ming Tan, Ern Yu Tan, Swee Ho Lim, Yu-Tang Gao, Ying Zheng, Daehee Kang, Ji-Yeob Choi, Wonshik Han, Han-Byoel Lee, Michiki Kubo, Yukinori Okada, Shinichi Namba, Sue K. Park, Sung-Won Kim, Chen-Yang Shen, Pei-Ei Wu, Boyoung Park, Kenneth R. Muir, Artitaya Lophatananon, Anna H. Wu, Chiu-Chen Tseng, Keitaro Matsuo, Hidemi Ito, Ava Kwong, Tsun L. Chan, Esther M. John, Allison W. Kurian, Motoki Iwasaki, Taiki Yamaji, Sun-Seog Kweon, Kristan J. Aronson, Rachel A. Murphy, Woon-Puay Koh, Chiea-Chuen Khor, Jian-Min Yuan, Rajkumar Dorajoo, Robin G. Walters, Zhengming Chen, Liming Li, Jun Lv, Keum-Ji Jung, Peter Kraft, Paul D.B. Pharoah, Alison M. Dunning, Jacques Simard, Xiao-Ou Shu, Cheng-Har Yip, Nur Aishah Mohd Taib, Antonis C. Antoniou, Wei Zheng, Mikael Hartman, Douglas F. Easton, Soo-Hwang Teo
Publikováno v:
Genetics in Medicine. 24:586-600
Purpose Non-European populations are under-represented in genetics studies, hindering clinical implementation of breast cancer polygenic risk scores (PRSs). We aimed to develop PRSs using the largest available studies of Asian ancestry and to assess
Autor:
Min-Min Tan, Weang-Kee Ho, Sook-Yee Yoon, Shivaani Mariapun, Siti Norhidayu Hasan, Daphne Shin-Chi Lee, Tiara Hassan, Sheau-Yee Lee, Sze-Yee Phuah, Kavitta Sivanandan, Patsy Pei-Sze Ng, Nadia Rajaram, Maheswari Jaganathan, Suniza Jamaris, Tania Islam, Kartini Rahmat, Farhana Fadzli, Anushya Vijayananthan, Pathmanathan Rajadurai, Mee-Hong See, Meow-Keong Thong, Nur Aishah Mohd Taib, Cheng-Har Yip, Soo-Hwang Teo
Publikováno v:
PLoS ONE, Vol 13, Iss 9, p e0203469 (2018)
BackgroundBreast cancer risk factors have been examined extensively in Western setting and more developed Asian cities/countries. However, there are limited data on developing Asian countries. The purpose of this study was to examine breast cancer ri
Externí odkaz:
https://doaj.org/article/0d9fd67f42d24c44b94caba1f4d0e565
Autor:
Jamil Omar, Mohamad Nasir Shafiee, Meow-Keong Thong, Daren C Y Teoh, Zatul Akmar Ahmad, Chun Sen Lim, Joanna Lim, Nellie Cheah, Angela George, Joseph K Joseph, Yeung Sing Chin, Soo-Hwang Teo, Doris S Y Chow, Badrul Zaman Abdullah, Eveline M. A. Bleiker, Boom Ping Khoo, Shahila Tayib, Teck Sin Tan, Suguna Subramaniam, Chee Kin Fong, Matin Mellor Abdullah, Soo Fan Ang, Yoke Ching Foo, John Low, Rakesh Raman, Yin Ling Woo, Kwong Sheng Loo, Siu Wan Wong, Ahmad Muzamir Ahmad Mustafa, Keng Joo Lim Lim, Sook-Yee Yoon, Nor Huda Mat Ali, Kean Fatt Ho, Kavitha Rethanavelu, Pei Jye Voon, Nur Tiara Hassan, Syuhada Ahmad, Ismail Aliyas, Beng Hock Teh, Mohd Pazudin Ismail, Heamanthaa Padmanabhan, Ileena Muin, Ghazali Ismail, Mastura Md Yusof, Chee Meng Yong, Muzhirah Haniffa, Azura Deniel, Mary Makanjang, Mohamad Faiz Mohamed Jamli, Rozita Abdul Malik, Noor Azmi Mat Adenan, Eunice S E Ong, Lye-Mun Tho, Anuradha Suberamaniam, Lip Hen Moey, Chui Ling Lee, Fuad Ismail, Winnie Peitee Ong, Vickneswaren Ramasamy, Arivendran Raja, Shao Yan Lau, Saw Joo Lee, Zarina Abdul Latiff, Boon Kiong Lim, Suresh Kumarasamy, Wee Teik Keng, Kin Wah Leong, Wee Wee Sim, Swee Kiong Kho, Gwo Fuang Ho, Azura Rozila Ahmad, Paul Hock Oon Ng, Mohd Norazam Mohd Abas, Mohd Rushdan Md Noor, A. B.Ahmad Radzi, Shivaani Mariapun, Gaik-Siew Ch'ng, Michael C K Lim
Publikováno v:
Journal of Medical Genetics. 59:220-229
BackgroundIdentifying patients with BRCA mutations is clinically important to inform on the potential response to treatment and for risk management of patients and their relatives. However, traditional referral routes may not meet clinical needs, and
Autor:
Arcangela De Nicolo, Diana M. Eccles, Sarah Louise Ariansen, Michela Biancolella, Miguel de la Hoya, Orland Diez, Hans Ehrencrona, Florentia Fostira, Tiara Hassan, Issei Imoto, Artur Kowalik, Fabienne Lesueur, Arjen R. Mensenkamp, Heli Nevanlinna, Joanne Ngeow, Edenir I. Palmero, Inge Søkilde Pedersen, Frances Que, Jana Soukupová, Yen Tan, Ana Vega, Amanda B. Spurdle, Paolo Radice
Publikováno v:
Cancer Research. 83:P6-02
Genetic testing for cancer susceptibility is a cornerstone of precision cancer prevention and care. Major communication hurdles remain for the differently specialized professionals involved in the identification, counselling, and clinical management